Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: Multifactorial states of clinical importance

Journal of Allergy and Clinical Immunology

Volumn 109, Issue 4, 2002, Pages 609-613

  Kino, Tomoshige ^a   Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; COMPLEMENTARY DNA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; RAP PROTEIN; RAP46 PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ASTHMA; CUSHINGOID SYNDROME; DISEASE COURSE; DNA RESPONSIVE ELEMENT; EDITORIAL; GENE STRUCTURE; GROWTH RETARDATION; HUMAN; IMMUNOCOMPETENT CELL; LUNG; MOLECULAR MECHANICS; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; SHORT STATURE; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

EID: 0036226710     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.123708     Document Type: Article

References (31)

1. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
2. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes
3. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
4. Decreased corticosensitivity in quiescent Crohn's disease: An ex vivo study using whole blood cell cultures
5. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving ARDS: Evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids
6. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: Neuro-endocrine and target tissue-related causes
7. Acquired immunodeficiency syndrome-related insulin resistance and lipodystrophy: A multifactorial viral and iatrogenic condition
8. p38MAP kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma
9. Inhaled corticosteroids: Impact on asthma morbidity and mortality
10. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 1. General principles
11. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of the literature
12. Alternative agents in asthma
13. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids
14. A novel action of IL-13: Induction of diminished monocyte glucocorticoid receptor-binding affinity
15. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor
16. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase
17. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain
18. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins
19. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins
20. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression
21. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
22. Glucocorticoid receptor beta: View I
23. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: Importance of the ligand-binding domain for intracellular GR trafficking
24. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor
25. Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex
26. Hsp70-RAP46 interaction in downregulation of DNA binding by glucocorticoid receptor
27. Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein
28. Functional modulation of the glucocorticoid receptor and suppression of NF-kappa B-dependent transcription by ursodeoxycholic acid
29. Thioredoxin: A redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system
30. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: Potential regulation of the glucocorticoid receptor
31. Inhibition of glucocorticoid receptor binding by nitric oxide